SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Paszat LF,Mackillop WJ,Groome PA, et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol. 1998; 16: 26252631.
  • 2
    Paszat LF,Mackillop WJ,Groome PA, et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys. 1999; 43: 755762.
  • 3
    Rutqvist LE,Lax I,Fornander T, et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992; 22: 887896.
  • 4
    Rutqvist LE,Johansson H. Mortality by lateralty of the primary tumour among 55000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer. 1990; 61: 866868.
  • 5
    Cuzick J,Stewart H,Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994; 12: 447453.
  • 6
    Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000; 355: 17571770.
  • 7
    Nixon AJ,Manola J,Gelman R, et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 1998; 16: 13741379.
  • 8
    Vallis KA,Pintilie M,Chong N, et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol. 2002; 20: 10361042.
  • 9
    Giordano SH,Kuo YF,Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005; 97: 419424.
  • 10
    Patt DA,Goodwin JS,Kuo YF, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005; 23: 74757482.
  • 11
    Prosnitz RG,Marks LB. Radiation-induced heart disease: vigilance is still required. J Clin Oncol. 2005; 23: 73917394.
  • 12
    Harris EER,Correa C,Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006; 24: 41004106.
  • 13
    Woodward WA,Strom EA,McNeese MD, et al. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys. 2003; 57: 327335.
  • 14
    Lamont EB,Christakis NA,Lauderdale DS. Favorable cardiac risk among elderly breast carcinoma survivors. Cancer. 2003; 98: 210.
  • 15
    Marks LB,Yu X,Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005; 63: 214223.
  • 16
    Pierce LJ,Griffith KA,Hayman JA, et al. Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys. 2005; 61: 13171327.
  • 17
    Overgaard M,Hansen PS,Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997; 337: 949955.
  • 18
    Overgaard M,Jensen MB,Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999; 353: 16411648.
  • 19
    Ragaz J,Jackson SM,Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997; 337: 956962.
  • 20
    National Hospital Discharge Survey. Available at URL: http://www.cdc.gov/nchs/about/major/hdasd/nhds.htm
  • 21
    United States Census. Available at URL: http://www.census.gov
  • 22
    Efron B,Tibshirani RJ. Monographs on Statistics and Applied Probability 57: An Introduction to the Bootstrap. Boca Raton, FL: Chapman & Hall/CRC; 1998.
  • 23
    Gyenes G,Gagliardi G,Lax I,Fornander T,Rutqvist LE. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol. 1997; 15: 13481353.
  • 24
    Das IJ,Cheng EC,Freedman G,Fowble B. Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1998; 42: 1119.
  • 25
    Pierce LJ,Moughan J,White J,Winchester DP,Owen J,Wilson JF. 1998–1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer. Int J Radiat Oncol Biol Phys. 2005; 62: 183192.
  • 26
    Cho BCJ,Schwartz M,Mijnheer BJ,Bartelink H. Simplified intensity-modulated radiotherapy using pre-defined segments to reduce cardiac complications in left-sided breast cancer. Radiother Oncol. 2004; 70: 231241.
  • 27
    Krauss DJ,Kestin LJ,Raff G, et al. MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2005; 61: 12431250.
  • 28
    Sixel KE,Aznar MC,Ung YC. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys. 2001; 49: 199204.
  • 29
    Pedersen AN,Korreman S,Nystrom H,Specht L. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol. 2004; 72: 5360.
  • 30
    Lu HM,Cash E,Chen MH, et al. Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys. 2000; 47: 895904.
  • 31
    Chen MH,Cash EP,Danias PG, et al. Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer. J Cardiovasc Magn Reson. 2002; 4: 265271.
  • 32
    Gladstone DJ,Flanagan MF,Southworth JB, et al. Radiation-induced cardiomyopathy as a function of radiation beam gating to the cardiac cycle. Phys Med Biol. 3004; 49: 14751484.
  • 33
    Darby SC,McGale P,Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6: 557565.
  • 34
    Rutqvist LE,Matteson A. Cardiac and thromboembolic morbidity among postmenopausal women with early stage breast cancer in a randomized trial of tamoxifen: the Stockholm Breast Cancer Study Group. J Natl Cancer Inst. 1993; 85: 13981406.
  • 35
    MacDonald CC,Alexander FE,Whyte BW, et al. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomized trial. BMJ. 1995; 311: 977980.
  • 36
    Constantino JP,Kuller LH,Ives DG,Fisher B,Dignam J. Coronary heart disease mortality and adjuvant tamoxifen therapy. J Natl Cancer Inst. 1997; 89: 776782.
  • 37
    Reis SE,Constantino JP,Wickerham DL, et al. Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. J Natl Cancer Inst. 2001; 93: 1621.
  • 38
    Barrett-Connor E,Grady D,Sashegyi A, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four-year results from the MORE (multiple outcomes of raloxifene evaluation) randomized trial. JAMA. 2002; 287: 847857.
  • 39
    Beral V,Banks E,Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 2002; 360; 942944.
  • 40
    Braithwaite RS,Chlebowski RT,Lau J, et al. Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med. 2003; 18: 937947.
  • 41
    Moschos SJ,Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology. 2002; 63: 317333.
  • 42
    Conti E,Marchese N,Andreotti F. Correspondence: favorable cardiac risk among elderly breast carcinoma survivors. Cancer. 2004; 100: 878879.
  • 43
    Conti E,Pitocco D,Capuluongo E, et al. IGF-1 and macrovascular complications of diabetes. Diabetes Care. 2003; 26: 16531654.
  • 44
    Van den Beld AW,Bots ML,Janssen JA,Pols HA,Lamberts SW,Grobbee DE. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol. 2003; 157: 2531.
  • 45
    Arciero TJ,Jacobsen SJ,Reeder GS, et al. Temporal trends in the incidence of coronary disease. Am J Med. 2004; 117: 228233.
  • 46
    Goldberg RJ,Yarzebski J,Lessard D,Gore JM. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999; 33: 15331539.